Microsoft Corporation (MSFT)

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 371.30 (as of 2026-06-29)

This is the panel's clearest "best value, worst tape" standoff — and, unusually, no one argues the business is broken. Microsoft fell ~33% from its ~$555 peak, but Azure reaccelerated to 40% growth, AI annual revenue hit a ~$37B run rate (up ~123%), ROE is ~34%, and the moat — Windows, Office, Azure switching costs plus Copilot upsell — is widening, not narrowing. The decline is almost entirely multiple compression (from ~35x to ~20x), not deterioration. The value and quality frameworks see that as opportunity: fair-value estimates run from $420 to $565, well above the price, and the GARP lens calls a sub-1.0 PEG "the market giving it away." The caution is about the chart and the cash: the stock sits ~18% below its long-term trend in a confirmed downtrend, and a sharply higher AI capex cycle cut free cash flow ~22% year-over-year, with ~45% of the contracted backlog tied to a single customer (OpenAI). The bulls say buy the de-rated quality now; the cautious say world-class business, wrong tape — wait for it to base. That split synthesizes to WAIT.

Key levels

Key resistance starts at ~$392 (the 50-week trend), then the ~$432 breakdown zone, up to the ~$477 level where the long-term trend signal flipped negative. Key support sits at ~$357 (the 2024 base and ~61.8% retracement), then ~$322, with a deeper historical accumulation zone near $287 (the 200-week trend). The analyst consensus target spans roughly USD 460 to 650, averaging near USD 565 — every Street target sits well above the current price, an unusually wide gap that reflects how much the analyst community reads the selloff as multiple compression rather than a broken thesis.

What legendary investors think

We ran Microsoft past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Is Microsoft a wide-moat compounder that the AI-capex scare has handed back at five-year-low multiples — or a still-richly-capitalized business whose free cash flow stays gutted long enough, and whose OpenAI dependence runs deep enough, that the broken tape is telling the truth?

The numbers

Metric	Value
Price / Market cap	USD 371.30 / ~2.77T
P/E (TTM / fwd)	~22x / ~19x (vs ~30–35x at the peak)
ROE	~34%
Operating margin	~45%
Dividend yield	~0.9%
Debt / equity	~0.30x (net cash)
Free cash flow	~USD 15.8B (Q3 FY2026, down ~22% YoY on the AI capex ramp)

Figures as of Q3 FY2026 (quarter ended March 2026) / June 2026; sourced from Microsoft IR/SEC filings, StockAnalysis, GuruFocus, MacroTrends, MarketBeat. Full-year AI capex figures vary by source (quarterly capex in the low-$30Bs; full-year estimates cited from ~$80B toward higher multi-year commitments); the consistent fact is a sharply higher build that cut free cash flow ~22% YoY. Forward multiples reflect consensus EPS; a normalized-earnings view (accounting for the depreciation ramp) yields a higher effective multiple.

The bottom line

Microsoft is the rare large-cap where almost every framework likes the business and several like the price — and the verdict still lands on patience, because the chart and the cash flow disagree with the value case for now. The bull argument is grounded and, on the latest quarter, accelerating: Azure reaccelerated to 40%, AI revenue compounds past a $37B run rate, the moat is widening through Copilot upsell across 300M+ commercial seats, ROE is ~34%, and the 33% drawdown compressed the multiple from the mid-30s to roughly 20x — handing the quality and value lenses fair-value estimates from $420 to $565, all above the price. The caution is equally concrete and, this quarter, dominant in the tape: the stock sits ~18% below its long-term trend in its worst month in a generation, a sharply higher AI capex cycle cut free cash flow ~22% with the depreciation ramp still building, and ~45% of the backlog leans on an OpenAI relationship that is diversifying away. What would tip the synthesis decisively bullish is the tape repairing — a reclaim of the long-term trend on volume — alongside free cash flow stabilizing as the capex cycle peaks, which would confirm the value frameworks are right that this is cheap rather than merely cheaper. What keeps it a wait is that, until the downtrend bases and the cash flow turns, the panel is being asked to catch a world-class business mid-fall — and the bulls who'd buy it here are outweighed, for now, by the voices saying the same company will be available with the tape on their side.

The panel's take

Verdict: BALANCED · Conviction: MEDIUM · Last price: USD 385.10 (as of 2026-07-11)

Microsoft is the panel's cleanest "own the quality, don't chase the tape" call. Nobody disputes the business: Azure reaccelerated to ~40% growth in Q3 FY2026, the AI business is at a ~$37B annualized run-rate (+123% YoY), commercial backlog sits at ~$627B, and the whole engine throws off ~30% ROE on minimal leverage. On the numbers it has actually gotten cheaper — ~23x trailing and ~20x forward, roughly a quarter below its own trailing-twelve-month average multiple — which is why the value, GARP, and innovation lenses all lean bullish and the analyst consensus target sits far above the price. But the split is real and it is about timing, not quality: the weekly chart is broken (down ~19% YTD, trading below a ~$440 200-day, lower highs and lower lows since the ~$555 top), and free cash flow fell despite record operating cash flow as AI capex climbed above $40B a quarter — a monetization bet the forensic and macro lenses refuse to underwrite until it shows up in cash. With three lenses saying "wonderful business, add on weakness," three saying "fair value, unconfirmed tape, prove the capex pays," and a Q4 FY2026 print landing July 29, the synthesis is BALANCED.

Key levels

Key resistance starts at ~$440 (broken 2025 support, now overhead supply near the falling Supertrend), then the ~$480 consolidation ceiling, up to the ~$555 all-time-high supply zone. Key support sits at ~$360 (the recent weekly swing low), then the ~$320 2024 breakout base, with a deeper historical accumulation zone near ~$280. The analyst consensus target spans roughly USD 400 to 680, averaging near USD 575 — well above the current price, an unusually wide Street-versus-tape gap that reflects the same debate the panel is having: cheap quality on fundamentals, unconfirmed on the chart.

What legendary investors think

We ran Microsoft past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Is Microsoft a rare chance to own the widest moat in software below its own historical multiple while the tape is temporarily broken — or a fairly-priced compounder whose record AI capex has to start converting to cash before the chart and the bulls are proven right?

The numbers

Metric	Value
Price / Market cap	USD 385.10 / ~2.87T
P/E (TTM / fwd)	~23x / ~20x (vs ~31x trailing-average)
Q3 FY2026 revenue / EPS	USD 82.9B (+18% YoY) / USD 4.27 (+21% YoY)
ROE / operating margin	~30% / ~45%
Azure / AI	Azure +40% YoY; AI run-rate ~$37B (+123%); backlog ~$627B
Dividend yield	~0.9% (20 consecutive annual increases)
Balance sheet	Debt/equity ~0.2; FY2025 FCF ~$71.6B (-3% YoY as capex ramps; Q3 capex ~$31.9B, Q4 guided >$40B)

Figures as of Q3 FY2026 (reported Apr 29, 2026) / July 11, 2026; sourced from Microsoft IR, CNBC, GuruFocus, MacroTrends, StockAnalysis, TIKR, Alphastreet. Azure 40% growth and the $37B AI run-rate are the reliable growth signals; the swing factor is capex intensity ($190B FY plan) compressing near-term FCF conversion. Analyst consensus ($560-590 avg) sits well above the price; Stifel's ~$400 is the low. Next print: July 29, 2026 (Q4 FY2026, after close).

The bottom line

Microsoft is the panel's most straightforward BALANCED verdict — a genuinely wonderful business whose price has fallen far enough to interest the value lenses, held back by a broken chart and an unresolved question about whether its AI capex converts to cash. The bull case is real and cheap by Microsoft's own standards: Azure back to ~40%, AI at a ~$37B run-rate, a ~$627B backlog, ~30% ROE, and a multiple roughly a quarter below its trailing average, which is why three independent lenses lean bullish and the Street consensus sits near $575. But the caution is equally concrete: free cash flow fell even as operating cash flow hit records because capex now runs above $40B a quarter, the stock is below its 200-day and down ~19% YTD while its own sector rallies, and the intrinsic-value work lands right around today's price rather than below it. What would tip the call decisively bullish is confirmation on both fronts — a clean Q4 FY2026 print on July 29 showing Azure durability and capex beginning to convert to free cash flow, plus a reclaim of the ~$440 200-day on volume. What keeps it BALANCED is that, until then, buyers are paying a fair price for a broken chart on the promise that the biggest capex cycle in the company's history pays off — the same wonderful business will be far easier to own once the cash flow and the tape confirm it.

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 393.82 (as of 2026-07-18) · Changed from BALANCED

What changed since 2026-07-11:

• Price: USD 385.10 → 393.82 (+2.3%) — a rally pushed into the $440 resistance shelf and printed as high as $465 before being rejected back down to retest $360 support, which held before the stock bounced.
• Panel: 3 of 6 → 1 of 6 now Bullish (The Moat Compounder and The GARP Operator moved to Neutral from Bullish) — the business case is now unanimous, but five of six lenses want the July 29 print to confirm AI capex is converting to free cash flow before adding conviction.
• Trigger: The July 29 Q4 FY2026 print; until then the panel is watching for a close-and-hold above $440 on volume.
• Verdict: BALANCED → WAIT

Every lens now agrees on the business — Azure at 40% growth, a $37B AI run-rate, and a $627B backlog make this one of the best businesses in the market — so the debate has narrowed entirely to timing. Five of six lenses read this week's failed test as unfinished business, not a broken thesis, and want confirmation — a clean print plus a reclaim of $440 — before adding capital. Only the disruptive-innovation lens is buying now, arguing the Supertrend flip off $360 already signals the market pricing the AI S-curve ahead of confirmation. With the business unanimous and the disagreement centered entirely on timing a known catalyst just eleven days out, the panel's synthesis moves from BALANCED to WAIT.

Key levels

Key resistance sits at ~$440 (the level this week's rally reached toward, peaking near $465 intraweek before closing back below it), then ~$480, up to the ~$555 all-time-high supply zone. Key support held again at ~$360 (a shelf tested and defended for a second time), then the ~$320 2024 breakout base, with a deeper historical accumulation zone near ~$280. The analyst consensus target spans roughly USD 400 to 680, averaging near USD 575 — a wide gap above the current price that mirrors the panel's own split: cheap on the fundamentals, not yet confirmed on the tape.

What legendary investors think

We ran Microsoft past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Does Microsoft's business quality already justify buying ahead of confirmation — or does the market need the July 29 print, and a real close above $440, to prove that record AI capex is converting into free cash flow rather than just compressing it?

The numbers

Metric	Value
Price / Market cap	USD 393.82 / ~2.94T
P/E (TTM / fwd)	~23.5x / ~20x (vs ~31x trailing-average)
Q3 FY2026 revenue / EPS	USD 82.9B (+18% YoY) / USD 4.27 (+21% YoY)
ROE / operating margin	~30% / ~45%
Azure / AI	Azure +40% YoY; AI run-rate ~$37B (+123%); backlog ~$627B
Dividend yield	~0.9% (20 consecutive annual increases)
Balance sheet	Debt/equity ~0.2; FY2025 FCF ~$71.6B (-3% YoY as capex ramps; Q3 capex ~$31.9B, Q4 guided >$40B)

Figures as of Q3 FY2026 (reported Apr 29, 2026) / July 18, 2026; sourced from Microsoft IR, CNBC, GuruFocus, MacroTrends, StockAnalysis, TIKR, Alphastreet. Azure 40% growth and the $37B AI run-rate are the reliable growth signals; the swing factor remains capex intensity ($190B FY plan) compressing near-term FCF conversion. Analyst consensus ($560-590 avg) sits well above the price; Stifel's ~$400 is the low. Next print: July 29, 2026 (Q4 FY2026, after close).

The bottom line

A close-and-hold above $440 on real volume would be the first tape confirmation for the five lenses currently on Neutral, independent of the earnings print. The July 29 Q4 FY2026 report is the swing event: free cash flow conversion improving from the FY2025 trend (down 3% to $71.6B despite capex above $40B a quarter) would resolve the forensic lens's core objection and likely pull the value and GARP lenses back toward Bullish. A close below $360 on volume, conversely, would be the first read that turns a business-quality skeptic's argument rather than a timing one — nobody on the panel expects that outcome today. Absent either signal, expect the panel to stay split between one lens already positioned for the AI S-curve and five waiting on the print eleven days out.

The panel's take

Verdict: WAIT · Conviction: MEDIUM · Last price: USD 381.70 (as of 2026-07-25)

What changed since 2026-07-18:

• Price: USD 393.82 → 381.70 (-3.08%) — the rally that had pushed into $440-465 faded back down, printing two flat weekly closes at 381.70 after a fresh rejection at $403-406. Note: the latest bar is a partial/low-volume week and should be read as provisional, not a confirmed close.
• Panel: composition unchanged — 1 of 6 still Bullish (The Disruptive-Innovation Seeker), 5 of 6 still Neutral, all five still parked on the same catalyst.
• Catalyst: the July 29 Q4 FY2026 print is now four days out (was eleven last week) — and now lands the same day as an FOMC decision, with rate-cut odds fading rather than firming.
• New risk: the nearest resistance moved closer, not farther — a genuine double-top at $403-406 (from the last two completed weekly bars) now sits between spot price and the $440 level the panel was watching, and the bounce into it came on declining volume, a mild distribution tell.
• New offset: a 10-year Databricks partnership extension and an AMD Helios inference deployment inside Azure data centers are margin-supportive signals since last week; separately, April's Microsoft-OpenAI agreement amendment cuts both ways — it de-risks the single-customer concentration (still ~45% of the $625-627B backlog) but opens a path for gradual workload migration off Azure.
• Verdict: WAIT (unchanged).

Nothing resolved this week — it just got four days closer to resolving. The business case stayed unanimous (Azure +40%, a $37B AI run-rate, ~30% ROE), and the stock actually got cheaper on that unchanged case, with the forward multiple compressing further toward ~20x. But the tape didn't reward the cheaper multiple: price faded from $393.82 to the $381-388 range, rejected again at a closer, freshly-confirmed $403-406 zone rather than testing the $440 level the panel had been watching, while Q3 free cash flow's 22% YoY decline against a still-widening $190-262B capex range kept the core objection alive. Five of six lenses hold their ground into a now-imminent catalyst; only the disruptive-innovation view continues to treat the capex ramp itself as the buy signal.

Key levels

The level that actually matters right now sits closer than the panel's prior trigger: $403-406 is the real double-top from the last two completed weekly bars, and price needs to clear that before $440 is even relevant again. Above it, $440 and $480 remain untested since April/May, with the 2025-07-28 all-time-high zone near $555 still the ceiling of the range. On the downside, $355-365 has now been defended twice (March and June 2026) and price sits comfortably above it. The deeper support commonly cited near $320 is more precisely the Aug 2023 low (~$311-320) — a level roughly three years untested, plausible as structural support but weaker than a recent-cycle floor. The previously cited $280 level has no supporting print anywhere in the OHLC record and is dropped this week pending deeper historical data. The analyst consensus band ($400 to $870, average near $580) sits well above spot — a gap that widened, not narrowed, since targets mostly held while price fell.

What legendary investors think

We ran Microsoft past a panel of six legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Does the panel's already-unanimous business case survive four more days of digestion and a same-day Fed decision without new evidence — or does Thursday's print, and a reclaim of the nearer $403-406 zone before $440 is even relevant, need to arrive first before five of six lenses move off Neutral?

The numbers

Metric	Value
Price / Market cap	USD 381.70 / ~2.84T
P/E (TTM / fwd)	~23.9x / ~20x (vs ~31x trailing-average)
Q3 FY2026 revenue / EPS	USD 82.9B (+18% YoY) / USD 4.27 (+21% YoY)
ROE / operating margin	~30% / ~45%
Azure / AI	Azure +40% YoY; AI run-rate ~$37B (+123%); backlog ~$625-627B (~45% tied to one customer)
Dividend yield	~0.9% (20 consecutive annual increases)
Balance sheet	FY2025 FCF ~$71.6B (-3% YoY); Q3 FCF ~$15.8B (-22% YoY) vs Q3 capex ~$30.9B; FY2026 capex guided ~$190-195B, FY2027 chatter spans $220-262B

Figures as of Q3 FY2026 (reported Apr 29, 2026) / July 25, 2026, with the latest weekly bar noted as partial/provisional; sourced from Microsoft IR, Robinhood, TradingKey, StartupHub, Motley Fool, StockAnalysis, AlphaQuery, 24/7 Wall St. Azure ~40% growth and the $37B AI run-rate remain the reliable growth signals; the swing factor is still capex intensity compressing near-term free cash flow conversion. Analyst consensus ($400-870 range, average ~$580) sits well above spot, a gap wider than the July 18 read since targets mostly held while price fell. Next print: July 29, 2026 (Q4 FY2026, after close), the same day as the July FOMC decision.

The bottom line

The July 29 print, four trading days out, remains the single event that can move five of six lenses off Neutral in either direction. A quarter showing free cash flow stabilizing or improving against the ~$190B FY2026 capex plan — with FY2027 guidance landing nearer the $220B end than the $262B high-end chatter — would resolve the forensic objection directly and likely pull the GARP and intrinsic-value lenses back toward Bullish, especially with the forward multiple already compressed to ~20x. A soft print, or guidance confirming capex is structurally outrunning cash generation, would harden the skeptical case without needing $355-365 to break first — the facts, not the chart, would do the work. Complicating either outcome, Thursday's report now shares a calendar day with an FOMC decision where rate-cut expectations have faded, adding a liquidity variable none of the other five lenses weight explicitly. Until then, with the nearest confirmed resistance now $403-406 rather than $440, and the defended floor at $355-365 still intact, the panel's synthesis holds exactly where it did last week: WAIT.

The panel's take

Verdict: WAIT · Conviction: MED · Last price: USD 464.72

What changed since 2026-07-25:

• Price: USD 381.70 → 464.72 (+21.8%) — a 22% one-week surge following the July 31 Q4 FY2026 earnings beat: revenue of $90B (+18% YoY, beat the $87.7B consensus), EPS of $4.81 (vs. $4.24 consensus), Azure accelerating to 43% YoY and guided to 45% next quarter, and commercial backlog (RPO) up 99% YoY to $627B.
• Panel: 1 of 6 → 5 of 6 now Bullish — composition also changed: added The Scuttlebutt Growth Investor, The Asymmetric Bargainer; removed The Forensic Skeptic, The Macro Opportunist.
• Trigger: BUY on a weekly close above USD 490 (weekly horizontal resistance), confirming the breakout has real follow-through. WAIT/accumulate on a pullback into the USD 427–435 zone (61.8% Fibonacci retracement, weekly volume point-of-control, and monthly EMA20 all cluster here) — the level both the price-discipline voices and the technical read point to as a historical accumulation zone. SELL on a weekly close below USD 427.33 (invalidating the recovery bounce) OR two consecutive quarters of sub-30% Azure growth OR a sequential decline in the $627B backlog.
• Verdict: WAIT (unchanged)

The business case flipped from contested to nearly unanimous in a single earnings print. A week ago the panel was split on whether the AI capex cycle would convert to durable cash flow; the July 31 report answered that question for five of six voices — Azure's acceleration, the $627B backlog, and a CFO who proactively dismantled the AI-overcapacity bear case on the call moved The Moat Compounder, The GARP Operator, The Scuttlebutt Growth Investor, The Intrinsic-Value Modeler, and The Disruptive-Innovation Seeker all into the bull camp. But the stock did the work for them — a 22% rally in a week means the price-discipline voices, The Asymmetric Bargainer chief among them, now see a fundamentally excellent business trading with no further margin of safety at $465, sitting directly against a monthly resistance level it hasn't yet cleared.

WAIT over BUY because the objection is price and timing, not business quality — nobody on the panel disputes the Azure/AI story anymore. WAIT over HOLD because there is no genuine disagreement about the thesis to sit and monitor; the cautious voices are explicit that they want to own MSFT, just not at a price with the easy money already made. The technical read agrees with that framing on its own terms: price is pressing directly against the nearest monthly resistance ($468.35) while the monthly MACD is still in a confirmed bearish posture even as the weekly momentum turns up — a genuine cross-timeframe conflict, not a clean breakout.

Key levels

What legendary investors think

We ran Microsoft Corporation past a panel of 6 legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Does Microsoft's July 31 earnings beat mark the start of a confirmed breakout — a weekly close above USD 490 that resolves the monthly-vs-weekly momentum conflict — or has the 22% rally already spent the margin of safety, leaving the USD 427–435 zone as the only place left to add without paying for news that's already public?

The numbers

Metric	Value
Price / Market cap	USD 464.72 / ~USD 3.0T
P/E (TTM / fwd)	25.89x / 23.71x
ROE	34.04%
Net margin	40.31%
Dividend yield	0.78%
Debt / equity	0.29x
Free cash flow	USD 66.99B (TTM)

Figures as of 2026-08-02; price as of the 2026-07-31 close ($464.72); sourced from stockanalysis.com.

The bottom line

The panel's business-quality verdict is no longer in question — five of six archetypes now call Microsoft an outright buy on fundamentals, up from one of six two weeks ago, on the strength of an earnings print that answered the AI-capex-conversion question the market had been waiting on. What keeps this WAIT rather than BUY is purely a price-and-timing objection: the stock is pressing against its nearest monthly resistance ($468.35) one week after a 22% rally, with the monthly MACD still bearish even as weekly momentum turns up. A confirmed weekly close above USD 490 would resolve that conflict and validate the breakout; a pullback into the USD 427–435 zone — where the deep-value and DCF-based voices both find their margin of safety — would be the cleaner entry. On the downside, two consecutive quarters of sub-30% Azure growth or a sequential decline in the $627B backlog would be the first sign the earnings beat was a peak, not a new base, and would override the price argument entirely.

The panel's take

Verdict: WAIT · Conviction: MED · Last price: 499.99

What changed since 2026-08-02:

• Price: 464.72 → 499.99 (+7.59%)
• Panel: 5 of 6 → 5 of 6 now Bullish — composition also changed: added The Forensic Skeptic, The Macro Opportunist; removed The Asymmetric Bargainer, The Disruptive-Innovation Seeker
• Trigger: A weekly close above $505.45 on expanding volume confirms the breakout and flips verdict to BUY. A weekly close below $427.19 (weekly POC / Fib 61.8%) breaks the recovery structure and flips to SELL.
• Verdict: WAIT (unchanged)

Since the prior article on August 2, 2026 (price $464.72), Microsoft surged 7.6% on a decisive Q4 FY2026 earnings beat that fundamentally reset the narrative: Azure growth accelerated to 40%+ constant currency, management explicitly guided for positive free cash flow in FY27, and 30M paid Copilot seats confirmed AI monetization is scaling. Two new panel voices, The Forensic Skeptic and The Macro Opportunist, introduced fresh scrutiny around free cash flow quality and technical resistance at $505. Combined with the stock now sitting directly beneath that level on thinning volume, that scrutiny kept the verdict at WAIT despite the fundamentally improved business story.

The split is BUY vs WAIT, not BUY vs SELL: all seven bullish voices plus both cautious voices agree Microsoft is a wonderful business, but the two dissenting voices (technical-scout and The Forensic Skeptic) flag that $500 sits beneath the $505.45 weekly Fib resistance into thinning volume, with a bearish monthly MACD, extreme bullish consensus, and deteriorating FCF quality. The structure rule for BUY vs WAIT splits routes to WAIT: the business is not in question, only the entry price and timing.

Key levels

What legendary investors think

We ran Microsoft Corporation past a panel of 6 legendary investors' frameworks.

Where they agree — and where they clash

The question it comes down to: Does the Q4 FY2026 earnings-driven narrative shift from "AI capex will destroy returns" to "AI monetization is accelerating" justify buying Microsoft at $500 beneath unconfirmed technical resistance, or does the combination of deteriorating free cash flow quality, thinning volume, and extreme bullish consensus warrant patience for either a confirmed breakout above $505 or a pullback to the $420–$440 accumulation zone?

The bottom line

• Breakout confirmation level: A weekly close above $505.45 on volume at least 20% above the 20-week average would confirm the recovery and likely trigger multiple expansion toward analyst consensus targets in the $555–$650 range.
• Key support to hold: A weekly close below $427.19 (the volume-weighted POC and 61.8% Fibonacci retracement) would break the recovery structure and open a retest of the $392 weekly SMA 200, invalidating the bull case.
• Next catalyst: F1Q FY2027 earnings in October 2026 will test whether Azure's 45% constant-currency growth guidance and the FY27 positive-FCF promise hold; any deviation from either would rapidly unwind the post-Q4 optimism.
• Risk to monitor: Free cash flow quality remains the central unresolved tension. The FY27 positive-FCF guidance is based on assumptions about capex peaking, and another quarter of declining FCF would validate The Forensic Skeptic's concern that the depreciation policy change is masking cash-generation weakness.